Influenza Virus Protein, Antibody, Gene cDNA Clone, ELISA Kit

· World Largest Influenza Virus Research Reagent Center        ·Over 600 Influenza Reagents
· HA, NA, NP, M1, NS1, NS2        · H1N1-H17N10; Influenza B        · Reagents cover more than 150 strains

Browse By Influenza Virus Reasearch Reagent Category

Broad-spectrum antibody to HA

Browse By Influenza Virus Molecule

Browse By Influenza Virus Subtype

H1N1 H1N2 H1N3 H1N8 H1N9 H2N2 H2N3 H2N8 H3N1 H3N2 H3N8 H4N4
H4N6 H4N8 H5N1 H5N2 H5N3 H5N8 H5N9 H6N1 H6N4 H6N8 H7N1 H7N2
H7N3 H7N7 H7N8 H7N9 H8N4 H9N2 H9N8 H10N3 H10N8 H10N9 H11N2 H11N6
H11N9 H12N1 H12N3 H12N5 H13N8 H14N5 H15N2 H15N8 H16N3 H17N10 Influenza B

Browse By Influenza Virus Strain

H1N1 A/Beijing/22808/2009 A/Brevig Mission/1/1918 A/Brisbane/59/2007
A/California/04/2009 A/California/07/2009 A/England/195/2009
A/New Caledonia/20/1999 A/New York/18/2009 A/Ohio/07/2009
A/Ohio/UR06-0091/2007 A/Puerto Rico/8/1934 A/Puerto Rico/8/34/Mount Sinai
A/Solomon Islands/3/2006 A/Texas/05/2009 A/WSN/1933
A/USSR/90/1977 A/New York/1/1918 A/Brisbane/59/2007,2008-2009
A/Chile/1/1983 A/Taiwan/01/1986 A/Beijing/262/1995
H1N2 A/swine/Guangxi/13/2006   
H1N3 A/duck/NZL/160/1976   
H1N8 A/Egyptian goose/South Africa/AI1448/2007   
H1N9 A/mallard/Ohio/265/1987    
H2N2 A/Ann Arbor/6/1960 A/Canada/720/2005 A/Japan/305/1957
H2N3 A/swine/Missouri/4296424/2006  
H2N8 A/herring gull/DE/703/1988  
H3N1 A/swine/Korea/PZ72-1/2006  
H3N2 A/Babol/36/2005 A/Brisbane/10/2007 A/Perth/16/2009
A/Victoria/210/2009 A/Wisconsin/67/X-161/2005 A/Wyoming/03/2003
A/Aichi/2/1968 A/reassortant/IVR-155 A/Hong Kong/1/1968
A/California/7/2004 A/Memphis/1/68 A/X-31
A/Fujian/411/2002 A/Wisconsin/15/2009 A/Victoria/361/2011
A/Hong Kong/CUHK31987/2011 A/Sydney/5/1997 A/Victoria/208/2009
A/Guangdong-Luohu/1256/2009 A/Moscow/10/1999 
H3N8 A/equine/Gansu/7/2008 A/canine/New York/145353/2008 
H4N4 A/mallard duck/Alberta/299/1977  
H4N6 A/mallard/Ohio/657/2002 A/Swine/Ontario/01911-1/99 
H4N8 A/chicken/Alabama/1/1975  
H5N1 A/Anhui/1/2005 A/bar-headed goose/Qinghai/14/2008 A/Cambodia/R0405050/2007
A/Cambodia/S1211394/2008 A/chicken/Egypt/2253-1/2006 A/chicken/India/NIV33487/2006
A/Common magpie/Hong Kong/2256/2006 A/Duck/Hong Kong/p46/1997 A/duck/Hunan/795/2002
A/duck/Laos/3295/2006 A/Egypt/2321-NAMRU3/2007 A/Egypt/N05056/2009
A/goose/Guiyang/337/2006 A/Hong kong/213/2003 A/Hong Kong/483/1997
A/Hubei/2011 A/Indonesia/5/2005 A/Japanese white-eye/Hong Kong/1038/2006
A/turkey/Turkey/1/2005 A/Vietnam/UT31413II/2008 A/whooper swan/Mongolia/244/2005
A/Xinjiang/1/2006 A/Vietnam/1194/2004 A/Vietnam/1203/2004
A/Egypt/3300-NAMRU3/2008 A/Thailand/1 (KAN-1) /2004 A/barnswallow/HongKong/D10-1161/2010
A/chicken/ Yamaguchi/7/2004 A/bar-headed goose/Qinghai/1A/2005 A/chicken/VietNam/NCVD-016/2008
A/common magpie/Hong Kong/5052/2007 A/goose/Guangdong/1/96 A/bar-headed goose/Qinghai/6/2008
H5N2 A/American green-winged teal/California/HKWF609/07 A/ostrich/South Africa/AI1091/2006 
H5N3 A/duck/Hokkaido/167/2007  
H5N8 A/duck/NY/191255-59/2002 A/turkey/Ireland/1378/1983 
H5N9 A/chicken/Italy/22A/1998  
H6N1 A/northern shoveler/California/HKWF115/2007  
H6N4 A/chicken/HongKong/17/77  
H6N8 A/mallard/Ohio/217/1998  
H7N1 A/turkey/Italy/4602/99  
H7N2 A/ruddy turnstone/New Jersey/563/2006  
H7N3 A/turkey/Italy/214845/2002  
H7N7 A/chicken/Netherlands/1/03 A/Netherlands/219/2003 A/equine/Kentucky/1a/1975
H7N8 A/mallard/Netherlands/33/2006  
H7N9 A/Anhui/1/2013 A/Hangzhou/1/2013 A/Pigeon/Shanghai/S1069/2013
A/Shanghai/1/2013 A/Hangzhou/3/2013 
A/Zhejiang/1/2013 A/Zhejiang/DTID-ZJU10/2013 A/Shanghai/4664T/2013
A/Shanghai/Patient3/2013 A/chicken/Zhejiang/DTID-ZJU01/2013 
H8N4 A/pintail duck/Alberta/114/1979  
H9N2 A/chicken/Hong Kong/G9/1997 A/Guinea fowl/Hong Kong/WF10/99 A/Hong Kong/1073/99
A/Hong Kong/35820/2009 A/duck/Hong Kong/448/78 A/Hong Kong/3239/2008
H9N8 A/chicken/Korea/164/04  
H10N3 A/duck/Hong Kong/786/1979 A/mallard/Minnesota/Sg-00194/2007 
H10N8 A/duck/Guangdong/E1/2012  
H10N9 A/duck/HongKong/562/1979  
H11N2 A/duck/Yangzhou/906/2002  
H11N6 A/duck/England/1/1956  
H11N9 A/mallard/Alberta/294/1977  
H12N1 A/mallard duck/Alberta/342/1983  
H12N3 A/bar headed goose/Mongolia/143/2005  
H12N5 A/green-winged teal/ALB/199/1991  
H13N8 A/black-headed gull/Netherlands/1/00  
H14N5 A/Mallard/Astrakhan(Gurjev)/263/1982  
H15N2 A/Australian shelduck/Western Australia/1756/1983  
H15N8 A/duck/AUS/341/1983  
H16N3 A/black-headed gull/Sweden/5/99  
H17N10 A/little yellow-shouldered bat/Guatemala/164/2009  
Influenza B B/Brisbane/60/2008 B/Florida/4/2006 B/Malaysia/2506/2004
B/Yamagata/16/1988 B/Massachusetts/03/2010 

Reagents for Pandemic & Avian Influenza

Influenza Related Information

Other virus research tools

HCMV virushiv virusEV71 virusCoronavirusRSVHPVSUDV
HCMV          HIV     EV71   CoV    RSV   HPV  SUDV

Other Products at Sino Biological


Influenza Background Information

Influenza (flu) is a respiratory infection in mammals and birds. It is caused by an RNA virus in the family Orthomyxoviridae. The virus is divided into three main types (Influenza A, Influenza B, and Influenza C), which are distinguished by differences in two major internal proteins (hemagglutinin (HA) and neuraminidase (NA)). Influenza virus type A is found in a wide variety of bird and mammal species and can undergo major shifts in immunological properties. Influenza virus type B is largely confined to humans and is an important cause of morbidity. Little is known about Influenza virus type C, which is not an important source of morbidity.

Influenza A is further divided into subtypes based on differences in the membrane proteins hemagglutinin (HA) and neuraminidase (NA), which are the most important targets for the immune system. The notation HhNn is used to refer to the subtype comprising the hth discovered Hemagglutinin (HA) protein and the nth discovered neuraminidase (NA) protein. The influenza viral Hemagglutinin (HA) protein is a homo trimer with a receptor binding pocket on the globular head of each monomer, and the influenza viral neuraminidase (NA) protein is a tetramer with an enzyme active site on the head of each monomer. Subtypes are further divided into strains; each genetically distinct virus isolate is usually considered to be a separate strain.

Influenza viruses that are known to infect human include the following sub-types. H1N1 virus that caused "Spanish Flu" (A/BrevigMission/1/1918(H1N1)) and seasonal flu (A/Brisbane/59/2007(H1N1), A/New Caledonia/20/1999(H1N1), and A/Solomon Islands/3/2006 (H1N1)) and a reassorted virus (A/California/04/2009(H1N1)) that caused the 2009 swine flu outbreak; H2N2 virus that caused the "Asian Flu"; H3N2 virus that caused the "Hong Kong Flu"; H5N1 "The Bird Flu" virus (A/Anhui/1/2005 (H5N1), A/Vietnam/1203/2004, A/Vietnam/1194/2004 (H5N1), A/bar-headed goose/Qinghai/14/2008 (H5N1), A/turkey/1/2005 (H5N1), A/Indonesia/5/2005 (H5N1)) that was the world's major influenza pandemic threat until the Swine Flu Pandemic of 2009; H7N7 virus that has unusual zoonotic potential; H1N2 is currently endemic in humans and pigs; and H9N2, H7N2, H7N3, H10N7 viruses.

Influenza research involves investigating molecular virology, pathogenesis, host immune responses, genomics, and epidemiology regarding influenza. The main goal of influenza research is to develop influenza countermeasures such as vaccines, therapies and diagnostic tools. Influenza virus vaccination is an effective approach to control influenza virus infection and pandemic spread of the virus. Each seasonal influenza vaccine contains hemagglutinin (HA) and neuraminidase antigen from three influenza subtype viruses-one subtype Influenza A H3N2 virus, one regular seasonal Influenza A H1N1 virus (not the 2009 H1N1 virus), and one Influenza B virus. Because of the influenza virus continues to mutate (antigen minor drifting or antigen major shifting) over time, the viruses in the vaccine change each year based on international surveillance and scientists' estimations about which types and strains of viruses will circulate in a given year. About 2 weeks after vaccination of the influenza viral antigen, antibodies that provide protection against influenza virus infection develop in the body.

Protection mechanism of influenza vaccine is well established to be neutralizing antibody (polyclonal human antibody) raised against influenza viral protein antigen such as the hemagglutinin (HA ) and neuraminidase (NA) protein antigen. Neutralizing antibody can block virus binding to host cells, block viral entry into host cells, and kill infected host cells. Recombinant monoclonal antibody (Mab, mouse monoclonal antibody, rabbit monoclonal antibody, chimeric monoclonal antibody, humanized monoclonal antibody) raised against the hemagglutinin (HA ) antigen or cloned from human B-cells (human monoclonal antibody) have shown to be promising anti-influenza infection product candidates.

At present, there are only three licensed anti-Influenza drugs namely Relenza (Zanamivir - ZMV), Tamiflu (Oseltamivir - OTV) and Amantadine/Rimantadine. The latter targets the M2 ion channel whereas the other compounds target neuraminidase (NA) and were designed through structure-based enzyme inhibitor programmes. Neuraminidase promotes influenza virus release from infected cells and facilitates virus spread within the respiratory tract. The neuraminidase inhibitors interfere with the release of progeny influenza virus from infected host cells, thereby halts the spread of infection in the respiratory tract. The influenza neuraminidase inhibitors are associated with very little toxicity and are far less likely to promote the development of drug-resistant influenza. In addition, the neuraminidase inhibitors are effective against all neuraminidase subtypes and, therefore, against all strains of influenza, a key point in epidemic and pandemic preparedness. Because of a broader antiviral spectrum, better tolerance, and less potential for emergence of resistance than is seen with the M2 inhibitors, the neuraminidase inhibitors represent an important advance in the treatment of influenza.